Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
18 | 3 | HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS//THROMBOSIS RESEARCH | 124610 |
518 | 2 | ASPIRIN RESISTANCE//ASPIRIN//THROMBOSIS RESEARCH | 15555 |
3852 | 1 | THROMBOXANE A2 RECEPTOR//THROMBOXANE A2//THROMBOXANE RECEPTOR | 1932 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | THROMBOXANE A2 RECEPTOR | authKW | 640938 | 3% | 62% | 63 |
2 | THROMBOXANE A2 | authKW | 381726 | 7% | 17% | 141 |
3 | THROMBOXANE RECEPTOR | authKW | 306050 | 2% | 45% | 42 |
4 | THROMBOXANE RECEPTOR ANTAGONIST | authKW | 229693 | 1% | 54% | 26 |
5 | THROMBOXANE SYNTHASE INHIBITOR | authKW | 182223 | 1% | 62% | 18 |
6 | THROMBOXANE ANTAGONISTS | authKW | 174579 | 1% | 63% | 17 |
7 | THROMBOXANE A2 RECEPTOR ANTAGONIST | authKW | 155325 | 1% | 48% | 20 |
8 | PICOTAMIDE | authKW | 138990 | 1% | 61% | 14 |
9 | KW 3635 | authKW | 125467 | 1% | 77% | 10 |
10 | THROMBOXANE SYNTHASE | authKW | 119815 | 1% | 28% | 26 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 7997 | 38% | 0% | 737 |
2 | Peripheral Vascular Diseases | 2983 | 12% | 0% | 233 |
3 | Chemistry, Medicinal | 2090 | 10% | 0% | 200 |
4 | Hematology | 1617 | 9% | 0% | 183 |
5 | Cardiac & Cardiovascular System | 1154 | 11% | 0% | 207 |
6 | Biochemistry & Molecular Biology | 399 | 16% | 0% | 311 |
7 | Endocrinology & Metabolism | 385 | 7% | 0% | 128 |
8 | Physiology | 209 | 5% | 0% | 88 |
9 | Cell Biology | 202 | 7% | 0% | 141 |
10 | Chemistry, Organic | 119 | 5% | 0% | 101 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INFLAMMAT PHARMACOL S | 36693 | 0% | 38% | 6 |
2 | EXPT HEMODYNAM HEMOLIEGE | 32623 | 0% | 100% | 2 |
3 | PHARMACOL 171 ASHLEY AVE | 29358 | 0% | 60% | 3 |
4 | WESTERN INFIRM SURG | 29358 | 0% | 60% | 3 |
5 | NAT SYNTH DRUG | 26093 | 0% | 40% | 4 |
6 | 124 SAGISU 5 CHOME | 21747 | 0% | 67% | 2 |
7 | KLINIKUM MANNHEIM CLIN CHEM | 21747 | 0% | 67% | 2 |
8 | POB 1005 | 21747 | 0% | 67% | 2 |
9 | HEMODYNAM HEMOLIEGE | 20070 | 0% | 31% | 4 |
10 | CELL MOLEC PHARMACOL EXPTL THER EUT | 18346 | 0% | 38% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 29667 | 2% | 5% | 38 |
2 | THROMBOSIS RESEARCH | 11293 | 4% | 1% | 85 |
3 | PROSTAGLANDINS | 11265 | 2% | 2% | 31 |
4 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 11061 | 2% | 2% | 36 |
5 | CARDIOVASCULAR DRUG REVIEWS | 8709 | 1% | 4% | 15 |
6 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 6284 | 2% | 1% | 35 |
7 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 5201 | 4% | 0% | 83 |
8 | EUROPEAN JOURNAL OF PHARMACOLOGY | 4547 | 5% | 0% | 90 |
9 | BRITISH JOURNAL OF PHARMACOLOGY | 3412 | 3% | 0% | 62 |
10 | EICOSANOIDS | 3333 | 0% | 4% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |